Cowen And Company, LLC Ionis Pharmaceuticals Inc Transaction History

Cowen And Company, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$43.39 - $51.63 $2.23 Million - $2.65 Million	51,415 New	51,415 $2.6 Million
Q2 2022 Aug 05, 2022	SELL	$31.71 - $43.0 $420,379 - $570,051	-13,257 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$29.88 - $37.04 $165,146 - $204,720	5,527 Added 71.5%	13,257 $491,000
Q4 2021 Feb 14, 2022	SELL	$25.61 - $35.1 $130,943 - $179,466	-5,113 Reduced 39.81%	7,730 $235,000
Q3 2021 Nov 12, 2021	SELL	$33.54 - $40.55 $498,572 - $602,775	-14,865 Reduced 53.65%	12,843 $431,000
Q2 2021 Aug 13, 2021	BUY	$34.54 - $47.25 $712,456 - $974,625	20,627 Added 291.3%	27,708 $1.11 Million
Q1 2021 May 04, 2021	BUY	$42.51 - $63.78 $301,013 - $451,626	7,081 New	7,081 $318,000
Q4 2020 Feb 08, 2021	SELL	$45.3 - $60.27 $365,163 - $485,836	-8,061 Closed	0 $0
Q3 2020 Nov 03, 2020	SELL	$47.45 - $62.95 $651,630 - $864,492	-13,733 Reduced 63.01%	8,061 $382,000
Q2 2020 Aug 13, 2020	BUY	$46.85 - $61.05 $46,709 - $60,866	997 Added 4.79%	21,794 $1.29 Million
Q1 2020 May 11, 2020	BUY	$41.6 - $63.4 $865,155 - $1.32 Million	20,797 New	20,797 $983,000

403

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.35B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Cowen And Company, LLC with notifications on news.